Benzinga Psychedelics Capital Conference

The global psychedelics market of drugs such as psilocybin, ketamine and LSD is booming and there are plenty of ways to get involved in the space. Several esteemed professionals in the space talked about ways to get exposure Thursday (April 13) at Benzinga's...

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nenad Yashruti, Business Development Director at Root Sciences, was a guest speaker at Benzinga's Cannabis Capital Conference on April 20, 2022. Root...

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Evan Levine, CEO and Chairman of PsyBio Therapeutics Corp (TSXV: PSYB) (OTCQB: PSYBF), was a guest speaker at Benzinga’s Psychedelic Capital Conference (...

Filament Health (OTCQB: FLHLF) (NEO:FH) is a clinical-stage psychedelic drug development company creating safe, standardized, naturally-derived psychedelic medicines.  CEO and Co-Founder Benjamin Lightburn spoke at the Benzinga Psychedelics Capital Conference, April 19, 2022, about the...

Daniel Carcillo, CEO and Founder of Wesana Health Holdings (OTCMKTS: WSNAF), was a guest speaker at Benzinga’s Psychedelic Capital Conference on April 19, 2022.  Wesana is a life science company pioneering developments in psychedelic treatments for mental health care.  Watch the...

Niar Naor, Chief Financial Officer at HMNC Brain Health, was a guest speaker at Benzinga’s Psychedelics Capital Conference on April 19, 2022. HMNC is a global psychiatry biopharma company pioneering the development of therapies for mental health disorders. Niar shares insights into HMNC...

Alex Enchin, Founder of HOLOS Global, was a guest speaker at Benzinga’s Psychedelic Capital Conference on April 20th, 2022. HOLOS is a leader in building wellness hospitality projects. Watch the full presentation here: This post contains sponsored advertising content. This content is for...

Photo by Hans Veth on Unsplash Scott Frohman, Founder and CEO of Odyssey Elixirs, was a guest speaker at Benzinga’s Psychedelic Capital Conference on April 19, 2022. Odyssey produces ready-to-drink, functional mushroom beverages. Watch the full presentation here: This post contains sponsored...

Daniel Carcillo is co-founder and CEO of Wesana Health (OTC: WSNAF), a data-driven life sciences company pioneering clinical therapies and drug development through the FDA pathway. A former NHL star, Carcillo won two Stanley Cups before retiring at the age of 30 due to Post-Concussion Syndrome...

From his beginnings at DuPont Merck to his current position as Cybin’s (NYSE: CYBN) CEO, Doug Drysdale has certainly had an eventful career. “I seem to be drawn to opportunities that are poised for growth, whether that is from being undermanaged, distressed or a startup situation,...

The first Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking investors, is coming to the Fontainebleau Miami Beach on April 19, 2022, in Miami, Florida. Enjoy exclusive opportunities for curated networking and unparalleled access to...